For PAAD, patients with low expression of NSUN2, NSUN3, TET1, TET3, and YBX1 had an optimistic prognosis, while overexpression of NSUN6, DNMT3B, TET2, and ALKBH1 had a similar predictive effect. Here, ALKBH1 is linked to pancreatic adenocarcinoma.